Tim Kutzkey, Director of Surrozen SRZN, has filed 35 purchases and 12 sales on the open market. Over the past 12 months that comes to a net purchase of $38.2M. The latest trade was on 05/13.

Tim Kutzkey

Director

Company: Surrozen SRZN
First filing: 23/01/17

Trades: 91 trades
Buys / sales: 35 / 12
12-month net buying: $38.2M
Last trade: 05/13

Trading activity

Transactions

	Trade type
TNYA	Open-market sale	02/24–02/25	02/26	4,170,266 sh4 trades	$0.57avg.	$2,374,855.36	−100.0%
TNYA	Open-market sale	02/20–02/23	02/24	829,734 sh4 trades	$0.61avg.	$503,077.74	−27.3%
TNYA	Open-market sale	02/10–02/11	02/12	4,400,290 sh4 trades	$0.69avg.	$3,040,317.58	−62.4%
EIKN	Open-market buy	02/06	02/09	2,117,760 sh3 trades	$18.00avg.	$38,119,680	No record
SRZN	Open-market buy	01/15–01/20	01/20	32,507 sh6 trades	$19.74avg.	$641,610.97	+3.3%
SRZN	Open-market buy	01/13–01/14	01/15	17,993 sh4 trades	$19.86avg.	$357,310.77	+1.8%
SRZN	Open-market buy	01/06	01/08	15,100 sh2 trades	$19.89avg.	$300,339	+1.5%
SRZN	Open-market buy	25/12/04–25/12/05	25/12/08	36,150 sh4 trades	$19.22avg.	$694,838.46	+3.8%
SRZN	Open-market buy	25/11/13	25/12/02	315,457 sh2 trades	$12.65avg.	$3,990,531.05	+48.7%
SRZN	Open-market buyAmendment	24/04/04	24/04/17	193,548 sh2 trades	$15.50avg.	$2,999,994	+145.0%
SRZN	Open-market buy	24/04/04	24/04/08	193,548 sh2 trades	$15.50avg.	$2,999,994	+138.9%
	Open-market buy	23/11/15–23/11/16	23/11/17	22,631 sh2 trades	$0.69avg.	$15,542.41	+2.4%
	Open-market buy	23/01/30–23/01/31	23/02/01	184,272 sh2 trades	$5.00avg.	$921,360	+24.8%
NGM Biopharmaceuticals	Open-market buy	23/01/23	23/01/25	9,900 sh	$5.00	$49,500	+1.4%
	Open-market buy	23/01/19–23/01/20	23/01/23	38,139 sh2 trades	$5.00avg.	$190,695	+5.5%
NGM Biopharmaceuticals	Open-market buy	23/01/12	23/01/17	5,378 sh	$4.95	$26,621.1	+0.8%
	Open-market buy	23/01/10–23/01/11	23/01/12	309,070 sh2 trades	$4.79avg.	$1,479,178.8	+81.2%